Publius Servilius Casca

Recent publications · Crossref

5 total works indexed

1. Isatuximab, carfilzomib, and dexamethasone in patients with relapsed multiple myeloma: updated results from IKEMA, a randomized Phase 3 study

   · 2023 · cited 84x

2. Primary outcomes by 1q21+ status for isatuximab-treated patients with relapsed/refractory multiple myeloma: subgroup analyses from ICARIA-MM and IKEMA

   · 2022 · cited 40x

3. Metamorphoses

   · 2004 · cited 24x

4. Amores

   · 1961 · cited 23x

5. Isatuximab plus carfilzomib–dexamethasone versus carfilzomib–dexamethasone in patients with relapsed multiple myeloma (IKEMA): overall survival analysis of a phase 3, randomised, controlled trial

   · 2024 · cited 20x

via Crossref · CC0